Calafat, Margalida http://orcid.org/0000-0003-2335-3792
González-Muñoza, Carlos
Fortuny, Marta
Roig, Cristina
Calm, Anna
Mombiela, Antonio
Cañete, Fiorella http://orcid.org/0000-0003-4589-9497
Bertoletti, Federico
González-González, Laura
Teller-Martín, Marta
Gordillo, Jordi
Mañosa, Míriam http://orcid.org/0000-0002-9051-2581
Garcia-Planella, Esther http://orcid.org/0000-0002-4325-0697
Domènech, Eugeni http://orcid.org/0000-0002-2315-7196
Article History
Received: 25 May 2021
Accepted: 16 June 2021
First Online: 23 June 2021
Declarations
:
: MC has served as a speaker or has received research or education funding or advisory fees from Takeda, Janssen, Faes Farma, and MSD; CG-M has served as speaker or has received research or education funding or advisory fees from Norgine, Janssen, Ferring; FC has served as a speaker or has received research or education funding or advisory fees from Takeda, Janssen, MSD, and Ferring; MM has served as a speaker or has received research or education funding or advisory fees from FAES, Ferring MSD, AbbVie, Takeda and Janssen; EG-P has served as a speaker and has received research and educational funding and advisory fees from MSD, AbbVie, Takeda, Kern Pharma, Pfizer, Janssen, Ferring, Shire Pharmaceuticals, and Tillots; ED has served as a speaker and has received research and educational funding and advisory fees from MSD, AbbVie, Takeda, Celltrion, Samsung Bioepis, Kern Pharma, Pfizer, Janssen, Celgene, Adacyte Therapeutics, Otsuka Pharmaceuticals, Ferring, Shire Pharmaceuticals, Tillots, Thermofisher, Grifols, Gilead, Roche and Gebro. The remaining authors declared no conflicts of interest.
: The study was approved by the Ethics Committees at both centers.
: All patients signed an informed consent form to participate in the local database.
Free to read: This content has been made available to all.